TickerFacts.

Palisade Bio, Inc. (PALI): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$15.72M
Year ended 2022-12-31
2009-12-31: -$10.38M2010-12-31: -$15.05M2011-12-31: -$12.80M2012-12-31: -$9.95M2013-12-31: -$12.28M2014-12-31: -$17.09M2015-12-31: -$18.81M2016-12-31: -$20.30M2017-12-31: -$13.02M2018-12-31: -$8.07M2019-12-31: -$8.49M2020-12-31: -$9.29M2021-12-31: -$41.85M2022-12-31: -$15.72M-$15.72M
2009-12-31 EBITDA (USD) 2022-12-31
Period endedEBITDAChange YoYSource filing
2022-12-31-$15.72Mn/m2024-03-26, From 2022-01-01
2021-12-31-$41.85Mn/m2023-03-22, From 2021-01-01
2020-12-31-$9.29Mn/c2022-03-17, From 2020-01-01
2019-12-31-$8.49Mn/m2021-03-22, From 2019-01-01
2018-12-31-$8.07Mn/m2020-03-27, From 2018-01-01
2017-12-31-$13.02Mn/m2019-03-22, From 2017-01-01
2016-12-31-$20.30Mn/m2018-04-02, From 2016-01-01
2015-12-31-$18.81Mn/m2017-03-23, From 2015-01-01
2014-12-31-$17.09Mn/m2016-03-14, From 2014-01-01
2013-12-31-$12.28Mn/m2016-03-14, From 2013-01-01
2012-12-31-$9.95Mn/m2015-03-16, From 2012-01-01
2011-12-31-$12.80Mn/m2014-03-10, From 2011-01-01
2010-12-31-$15.05Mn/m2012-03-30, From 2010-01-01
2009-12-31-$10.38Mn/a2012-03-30, From 2009-01-01